|
Volumn 18, Issue , 2004, Pages 151-164
|
Pharmacoeconomic considerations for allergen immunotherapy.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ASTHMA;
COST;
DESENSITIZATION;
ECONOMICS;
HUMAN;
MEDICAL FEE;
PATIENT SELECTION;
PERENNIAL RHINITIS;
PHARMACOECONOMICS;
PREVALENCE;
REVIEW;
TREATMENT OUTCOME;
UNITED STATES;
ASTHMA;
COSTS AND COST ANALYSIS;
DESENSITIZATION, IMMUNOLOGIC;
ECONOMICS, PHARMACEUTICAL;
FEE-FOR-SERVICE PLANS;
HUMANS;
PATIENT SELECTION;
PREVALENCE;
RHINITIS, ALLERGIC, PERENNIAL;
TREATMENT OUTCOME;
UNITED STATES;
|
EID: 2142711033
PISSN: 10757910
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (17)
|
References (60)
|